Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.
about
The role of epigenetics in kidney malignanciesHistone deacetylases as targets for treatment of multiple diseasesCancer Epigenetics: Mechanisms and Crosstalk of a HDAC Inhibitor, VorinostatEpigenetic drugs against cancer: an evolving landscape.Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells.GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axisHistone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide3-kinase / ERK-MMP-laminin5γ2 signaling pathwayCurcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity.Epithelial to mesenchymal transition is associated with rapamycin resistanceFisetin inhibits growth, induces G₂ /M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation.TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth.Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice.Erb-041, an estrogen receptor-β agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway.Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients.Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?Histone deacetylases function as a novel potential therapeutic target for cancer.Histone modifiers: Dynamic regulators of the cutaneous transcriptome.Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells.Assessment of Tissue Level of Histone Deactylase-2 (HDAC-2) in Patients With Mycosis Fungoides.
P2860
Q26801233-28712849-3608-427F-B013-082E8C5FB908Q27000389-78A9D43B-003F-4098-81DB-2DE8587C6D71Q34213967-E5DE4885-3741-4ECC-865B-F72E4C477B6EQ34431964-7D018057-396A-4E6E-9F41-357F10AA8258Q34587139-12CE0B81-A0EC-4B06-ACB6-A55A81CF4DC6Q35067950-B64DD3C5-7FE2-48F5-BE7F-45A72CE825B2Q35904204-59905FA9-A0BD-4080-8F0F-C482B4379AACQ35989409-3D5D9D5E-2E2C-4FCC-A975-DCEB054055DAQ36002405-761420D5-8A4E-4704-83F0-98C9BCE31DBEQ36260570-B3B6BCBB-2F00-473A-A694-23AFF717876AQ37051658-550B3D72-9D61-4D1B-951B-C668A728EFA6Q37420163-6B6FDA64-38EA-4802-9299-C9F9D10C52A7Q37582051-2D3585D8-E40C-4014-A726-910D53D9E38AQ37624094-7E7C1316-AAB3-4556-903C-326C842D33A1Q38187197-4251A700-50C5-41EC-8B88-0A8A15493D1FQ38328785-BA7C59F3-5889-4132-BEF5-36A2D667927DQ38908331-16B1F70C-10E7-4F1F-8E02-AE9BC10823F2Q47253268-131A1249-8346-46C6-B89E-916ED778A406Q47324023-B55A1669-D855-4CC4-B5EB-7ED871B8651DQ52901914-6A839A88-CB47-4A7D-A0CF-8FE86DCF6B94Q52939500-AFDE5F52-A2E6-47DC-BF31-3EA4DEE69FC5
P2860
Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Vorinostat, an HDAC inhibitor ...... human xenograft murine model.
@ast
Vorinostat, an HDAC inhibitor ...... human xenograft murine model.
@en
type
label
Vorinostat, an HDAC inhibitor ...... human xenograft murine model.
@ast
Vorinostat, an HDAC inhibitor ...... human xenograft murine model.
@en
prefLabel
Vorinostat, an HDAC inhibitor ...... human xenograft murine model.
@ast
Vorinostat, an HDAC inhibitor ...... human xenograft murine model.
@en
P2093
P2860
P1476
Vorinostat, an HDAC inhibitor ...... human xenograft murine model.
@en
P2093
Craig A Elmets
Deepali Kurundkar
Levy Kopelovich
Mohammad Athar
Ritesh K Srivastava
Sandeep C Chaudhary
P2860
P304
P356
10.1016/J.TAAP.2012.11.002
P577
2012-11-09T00:00:00Z